semaglutide prediabetes progression to diabetes step trial 2·4 mg once a week in adults with overweight or obesity, and type 2 (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 Semaglutide, exenatide, and their relatives

It helps regulate blood sugar through incretin-related effects, including glucose-dependent insulin release and slower stomach emptying

Combined with expanding therapeutic applications, this represents a fundamental shift in how NCDs are treated

Heres what well cover in this blog post: Why commitment matters for GLP-1 therapy The different stages of GLP-1 therapy What to expect after 18 months When considering getting started with GLP-1, its easy to wonder what the commitment will be: how long do you have to commit to get the results youre looking for, and when does the commitment end

Abuse (such as taking higher doses or using old meds recreationally) is not protected